Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples